Gartner Blog Network

Hype Cycle for 3D Printing is Out

by Michael Shanler  |  July 22, 2016  |  Comments Off on Hype Cycle for 3D Printing is Out

People are doing a hell of a lot more than 3D-printing personalized bobble heads and cheap chess pieces.   Granted, there is still a lot of “hype” about the technologies… but many of us  have already experienced the impacts of 3DP without even realizing it.

We’ve walked in shoes with 3DP soles. We’ve been driven in cars with 3DP components.  We’ve flown on planes with 3DP parts. We’ve worn personalized 3DP hearing aids.  We’ve had our teeth fixed with 3DP braces. We’ve had 3DP knees, hips, and skull fragments implanted.   We’ve been operated on by doctors with 3DP surgical tools. We’ve researched tissues with 3DP “bio-ink”.   The list goes on and on…  This is just the beginning.

This is the 3rd year for this Hype Cycle.  For 2016, the Gartner team added 15 new technology profiles, bringing the total to 37. The new additions include:

  • More industry-specific 3DP technologies : Aerospace and defense, automotive and pharmaceutical manufacturing, consumer wearables, and electronic fabrication.
  • More technology-driven processes and techniques: 3D printing workflow software, 4D printing, augmented manufacturing for supply chain and nanoscale printing.
  • The Seven core printing technologies: Binder jetting, directed-energy deposition, material extrusion, material jetting, powder bed fusion, sheet lamination and stereolithography.

For more details see the doc link:    Hype Cycle for 3D Printing, 2016
19 July 2016 G00307807 Analyst(s): Michael Shanler | Pete Basiliere

Additional Resources

View Free, Relevant Gartner Research

Gartner's research helps you cut through the complexity and deliver the knowledge you need to make the right decisions quickly, and with confidence.

Read Free Gartner Research

Category: 3d-printing  additive-manufacturing  engineering  gartner  innovation  manufacturing  product-development  rd  

Michael Shanler
Research VP
5 years at Gartner

Michael Shanler covers life science R&D technologies. Read Full Bio

Comments are closed

Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.